Evogene Ltd. EVGN
0.36 USD -0.01 -2.86%
As of Nov 2, 1:21 PM ET
- YTD
- -66.92%
- 1 year
- -71.12%
- Open
- 0.3669
- Prev close
- 0.3746
- Mkt cap
- 4.94M
- Vol
- 21.24K
- Avg vol
- 1.42M
- EPS
- -1.55
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.36
- High
- 0.3742
- Forward P/E
- -0.39
- Beta
- 1.08
- Short ratio
- 0.04
- Inst. own
- 11.12%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.87
- 200-d avg
- 4.76
- 1y target
- 8.13
5D chart
Chart tools
Chart is warming up
The five-day price history for EVGN has not been loaded yet. Try again in a moment.
Altman Z-Score
-32.49 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -1.0×
P/S 2.2×
P/B -106×
P/FCF -0.6×
EV/EBITDA 0.2×
EV/Sales -0.5×
FCF Yield -157.4%
Gross Margin -6.3%
Operating Margin -364.2%
Net Margin -220.2%
ROE 10347.6%
ROIC -81.0%
ROA -42.3%
Revenue -30.9%
Operating Income 25.4%
EPS (diluted) 62.6%
Free Cash Flow 32.9%
Current Ratio 4.5×
Quick Ratio 4.5×
Debt / Equity -26.8×
Net Debt / EBITDA 0.9×
Interest Coverage -7.4×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31